Trial Profile
Clinical Trials Insight: 700059169
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 10 Sep 2010
Price :
$35
*
At a glance
- Drugs Elafibranor (Primary)
- Indications Lipid metabolism disorders; Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 09 Sep 2010 Results reported in a Genfit media release
- 09 Sep 2010 New trial record